Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New DNA test could speed up fungal infection diagnosis in cancer patients

NCT ID NCT03349931

First seen Nov 20, 2025 · Last updated Jun 17, 2026 · Updated 31 times

Summary

This study tested a new DNA test called the MycoGenie kit to see how well it can diagnose invasive aspergillosis, a serious fungal infection, in 350 blood cancer patients. The test looks for the fungus's DNA in blood samples and can also detect drug resistance. The goal is to find a faster, more accurate way to diagnose this infection in high-risk patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHRU de Lille, Hôpital Claude Huriez

    Lille, 59000, France

  • CHU Bordeaux, Groupe hospitalier

    Bordeaux, 33000, France

  • CHU de DIJON, Hôpital du bocage

    Dijon, 21000, France

  • CHU de Nantes, Hôpital de Moncousu

    Nantes, 44000, France

  • CHU de RENNES, hôpital de Pontchaillou

    Rennes, 35000, France

  • Hôpital Necker - Enfants maladies (AP-HP)

    Paris, Paris, 75015, France

Conditions

The condition(s) this trial relates to.

aspergillosis invasive aspergillosis leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.